Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) is expected to release its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect Protagonist Therapeutics to post earnings of ($0.5415) per share and revenue of $14.9160 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for [...]
Protagonist Therapeutics (PTGX) Expected to Announce Quarterly Earnings on Wednesday
